These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23664488)

  • 1. Differential expression of ubiquitin carboxy-terminal hydrolase L1 in breast carcinoma and its biological significance.
    Lien HC; Wang CC; Lin CH; Lu YS; Huang CS; Hsiao LP; Yao YT
    Hum Pathol; 2013 Sep; 44(9):1838-48. PubMed ID: 23664488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin carboxy-terminal hydrolase L1 may be involved in the development of mammary phyllodes tumors.
    Lien HC; Wang CC; Huang CS; Yang YW; Kuo WH; Yao YT
    Virchows Arch; 2013 Feb; 462(2):155-61. PubMed ID: 23291960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UCH-L1 involved in regulating the degradation of EGFR and promoting malignant properties in drug-resistant breast cancer.
    Jin Y; Zhang W; Xu J; Wang H; Zhang Z; Chu C; Liu X; Zou Q
    Int J Clin Exp Pathol; 2015; 8(10):12500-8. PubMed ID: 26722437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of hyaluronan synthase 2 in breast carcinoma and its biological significance.
    Lien HC; Lee YH; Jeng YM; Lin CH; Lu YS; Yao YT
    Histopathology; 2014 Sep; 65(3):328-39. PubMed ID: 24527698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histogenesis of metaplastic breast carcinoma and axillary nodal metastases.
    Osako T; Horii R; Ogiya A; Iijima K; Iwase T; Akiyama F
    Pathol Int; 2009 Feb; 59(2):116-20. PubMed ID: 19154267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of iTRAQ-based quantitative proteomic identification of CHGA and UCHL1 correlated with lymph node metastasis in colorectal carcinoma.
    Lee KC; Chen HH; Cheng KC; Liu TT; Lee KF; Teng CC; Huang CY; Hsieh MC; Kuo HC
    J Cell Mol Med; 2023 Jul; 27(14):2004-2020. PubMed ID: 37246623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibronectin expression in carcinoma cells correlates with tumor aggressiveness and poor clinical outcome in patients with invasive breast cancer.
    Bae YK; Kim A; Kim MK; Choi JE; Kang SH; Lee SJ
    Hum Pathol; 2013 Oct; 44(10):2028-37. PubMed ID: 23684510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin carboxy-terminal hydrolase L1 - physiology and pathology.
    Matuszczak E; Tylicka M; Komarowska MD; Debek W; Hermanowicz A
    Cell Biochem Funct; 2020 Jul; 38(5):533-540. PubMed ID: 32207552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors.
    Yu J; Tao Q; Cheung KF; Jin H; Poon FF; Wang X; Li H; Cheng YY; Röcken C; Ebert MP; Chan AT; Sung JJ
    Hepatology; 2008 Aug; 48(2):508-18. PubMed ID: 18666234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Expression of Ubiquitin C-terminal Hydrolase L1 Is Associated With Poor Prognosis in Endometrial Cancer Patients.
    Nakao K; Hirakawa T; Suwa H; Kogure K; Ikeda S; Yamashita S; Minegishi T; Kishi H
    Int J Gynecol Cancer; 2018 May; 28(4):675-683. PubMed ID: 29489474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPOCK1 Is a Novel Transforming Growth Factor-β-Induced Myoepithelial Marker That Enhances Invasion and Correlates with Poor Prognosis in Breast Cancer.
    Fan LC; Jeng YM; Lu YT; Lien HC
    PLoS One; 2016; 11(9):e0162933. PubMed ID: 27626636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous expression and biological function of ubiquitin carboxy-terminal hydrolase-L1 in osteosarcoma.
    Zheng S; Qiao G; Min D; Zhang Z; Lin F; Yang Q; Feng T; Tang L; Sun Y; Zhao H; Li H; Yu W; Yang Y; Shen Z; Yao Y
    Cancer Lett; 2015 Apr; 359(1):36-46. PubMed ID: 25578779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin C-terminal hydrolase L1 promotes lymph node metastasis in small cell neuroendocrine carcinomas of the cervix.
    Zhang Y; Ding J; Zhang X; Hua K
    J Int Med Res; 2022 Apr; 50(4):3000605221087620. PubMed ID: 35400238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrillin-1, a novel TGF-beta-induced factor, is preferentially expressed in metaplastic carcinoma with spindle sarcomatous metaplasia.
    Lien HC; Lee YH; Juang YL; Lu YT
    Pathology; 2019 Jun; 51(4):375-383. PubMed ID: 31010590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology.
    Mondal M; Conole D; Nautiyal J; Tate EW
    Br J Cancer; 2022 Jan; 126(1):24-33. PubMed ID: 34497382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinctive role of SIRT1 expression on tumor invasion and metastasis in breast cancer by molecular subtype.
    Chung YR; Kim H; Park SY; Park IA; Jang JJ; Choe JY; Jung YY; Im SA; Moon HG; Lee KH; Suh KJ; Kim TY; Noh DY; Han W; Ryu HS
    Hum Pathol; 2015 Jul; 46(7):1027-35. PubMed ID: 26004371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SIRT1 induces tumor invasion by targeting epithelial mesenchymal transition-related pathway and is a prognostic marker in triple negative breast cancer.
    Jin MS; Hyun CL; Park IA; Kim JY; Chung YR; Im SA; Lee KH; Moon HG; Ryu HS
    Tumour Biol; 2016 Apr; 37(4):4743-53. PubMed ID: 26515337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of invasive micropapillary and triple negative invasive ductal carcinoma of the breast.
    Chen HL; Ding A
    Breast; 2015 Dec; 24(6):723-31. PubMed ID: 26392199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase-2 (MMP-2) and MMP-9 expression in invasive ductal carcinoma of the breast.
    Sullu Y; Demirag GG; Yildirim A; Karagoz F; Kandemir B
    Pathol Res Pract; 2011 Dec; 207(12):747-53. PubMed ID: 22030137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensive retraction artifact correlates with lymphatic invasion and nodal metastasis and predicts poor outcome in early stage breast carcinoma.
    Acs G; Dumoff KL; Solin LJ; Pasha T; Xu X; Zhang PJ
    Am J Surg Pathol; 2007 Jan; 31(1):129-40. PubMed ID: 17197929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.